[Evaluation of the hormonal constitution variants in regard to the prescription of oral contraceptives].
D000085:Acetates / Q000009:adverse effects; D000568:Amenorrhea / Q000139:chemically induced; D000728:Androgens / Q000009:adverse effects*; D001824:Body Constitution; D001835:Body Weight / Q000187:drug effects; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000145:classification*; D003864:Depression, Chemical; D004967:Estrogens / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007989:Libido / Q000187:drug effects; D008234:Lynestrenol / Q000009:adverse effects; D008535:Megestrol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D009325:Nausea / Q000139:chemically induced; D009640:Norethindrone / Q000009:adverse effects; D009641:Norethynodrel / Q000009:adverse effects; D009644:Norgestrel / Q000009:adverse effects; D010919:Placebos; D011372:Progestins / Q000009:adverse effects*
D000085:Acetates; D000728:Androgens; D003276:Contraceptives, Oral; D004967:Estrogens; D010919:Placebos; D011372:Progestins; D002715:Chlormadinone Acetate; D009644:Norgestrel; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D008656:Mestranol; D008535:Megestrol; D008234:Lynestrenol; D009640:Norethindrone
Die Beurteilung hormonaler Konstitutionsvarianten im Hinblick auf die Verordnung von Oralen Kontrazeptiva.